Skip to main content
    S

    SBC Medical Group Holdings Incorporated (SBC)

    Official site

    INDUSTRIALS • CONSULTING SERVICES • NASDAQ

    $6.18
    -1.17 (-15.92%)

    Market Cap: $755.92M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    SBC Medical Group Holdings Incorporated (SBC) Financials: Revenue, Profit and Cash Flow

    Updated Nov 13, 2026. Financial statements from company filings, amounts in US dollars.

    SBC Medical Group Holdings reported revenue of $173.61M for the fiscal year ended Dec 31, 2025, down 15.5% from the year before. That year, net income was $51.05M with a net margin of 29.4%, operating cash flow was $24.67M and free cash flow was $23.27M. The quarter ended Sep 30, 2026 had revenue of $58.58M and net income of $16.42M.

    Revenue and Margins

    The operating margin was 38.9% in the fiscal year ended Dec 2025, the highest of the 4 years shown.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$173.61M-15.5%73.3%38.9%29.4%
    Dec 2024$205.42M+6.1%76.0%34.2%22.7%
    Dec 2023$193.54M+11.1%70.9%36.5%19.9%
    Dec 2022$174.16MN/A65.9%11.6%3.6%
    Annual, fiscal years ended Dec 2022 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 9.3% from the year before. In the quarter ended Sep 2026, net income rose 28.0% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022
    Revenue$173.61M$205.42M$193.54M$174.16M
    Cost of revenue$46.32M$49.37M$56.24M$59.33M
    Gross profit$127.28M$156.05M$137.30M$114.83M
    Operating income$67.49M$70.30M$70.66M$20.12M
    Net income$51.05M$46.69M$38.56M$6.32M
    EBITDA$84.71M$77.26M$85.78M$29.64M
    Fiscal years ended Dec 2022 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$58.58M$49.19M$43.06M$39.57M$43.35M$43.36M$47.33M$44.42M$53.08M$53.10M$54.81M$146.26M
    Gross profit$42.18M$35.98M$30.35M$28.93M$30.61M$30.01M$37.73M$33.87M$43.24M$39.42M$39.52M$103.86M
    Operating income$26.42M$18.96M$17.72M$12.85M$15.88M$14.55M$24.20M$4.72M$13.83M$27.29M$24.46M$51.50M
    Net income$16.42M$11.16M$11.33M$14.28M$12.83M$2.44M$21.49M$6.55M$2.83M$18.56M$18.75M$29.69M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $42.83M by $120.94M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022
    Total assets$380.45M$266.08M$258.81M$119.94M
    Current assets$231.22M$184.45M$165.91M$722.19K
    Cash and equivalents$163.77M$125.04M$103.02M$485.56K
    Total liabilities$117.14M$71.06M$115.00M$4.59M
    Short-term debt$9.10M$123.08K$3.53M$0
    Long-term debt$33.73M$6.51M$13.01M$5.53M
    Shareholder equity$248.28M$195.11M$142.16M-$3.36M
    Fiscal years ended Dec 2022 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$424.82M$406.66M$388.02M$380.45M$321.36M$315.30M$284.61M$266.08M$296.48M$19.53M$19.75M$258.81M
    Total liabilities$121.35M$126.74M$117.64M$117.14M$73.30M$70.65M$58.28M$71.06M$90.96M$8.51M$8.43M$115.00M
    Cash and equivalents$198.43M$184.31M$167.31M$163.77M$127.43M$152.74M$132.06M$125.04M$137.39M$1.38M$1.66M$103.02M
    Shareholder equity$286.85M$263.84M$255.34M$248.28M$247.99M$244.59M$226.45M$195.11M$204.98M$8.83M$9.02M$142.16M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 94.3% of operating cash flow. Share repurchases came to 21.5% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022
    Operating cash flow$24.67M$20.58M$50.67M-$47.37K
    Capital expenditures$1.40M$2.56M$8.54M$24.95M
    Free cash flow$23.27M$18.02M$42.13M-$24.99M
    Share repurchases$5.00M$0N/AN/A
    Investing cash flow-$20.97M-$10.10M$1.79M-$32.65M
    Financing cash flow$38.29M$22.97M$6.14M-$7.98M
    Fiscal years ended Dec 2022 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$18.51M$22.51M$9.23M$51.96M-$20.88M-$8.34M$1.93M-$7.30M$5.01M$19.19M$3.68M$27.92M
    Capital expenditures$1.01M$84.40K$125.00K$797.53K$43.05K$306.71K$253.72K$590.36K$408.95K$863.05K$702.28K$6.24M
    Free cash flow$17.50M$22.42M$9.11M$51.17M-$20.93M-$8.65M$1.67M-$7.89M$4.60M$18.33M$2.98M$21.67M
    Last 12 quarters

    Frequently Asked Questions About SBC

    What is SBC Medical Group Holdings' annual revenue?

    SBC Medical Group Holdings reported revenue of $173.61M for the fiscal year ended Dec 31, 2025.

    How fast is SBC Medical Group Holdings' revenue growing?

    Revenue was down 15.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -0.1%.

    Is SBC Medical Group Holdings profitable?

    Yes. SBC Medical Group Holdings reported net income of $51.05M for the fiscal year ended Dec 31, 2025, with a net margin of 29.4%.

    How much free cash flow does SBC generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $24.67M minus capital expenditures of $1.40M produced free cash flow of $23.27M.

    How much debt does SBC Medical Group Holdings have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $33.73M, short-term debt of $9.10M and cash and equivalents of $163.77M.